Elanco Animal Health Shares Outstanding 2016-2026 | ELAN
Elanco Animal Health shares outstanding history from 2016 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Elanco Animal Health shares outstanding for the quarter ending March 31, 2026 were 506M, a 1.38% increase year-over-year.
- Elanco Animal Health 2025 shares outstanding were 0.496B, a 0.18% decline from 2024.
- Elanco Animal Health 2024 shares outstanding were 0.497B, a 1.02% increase from 2023.
- Elanco Animal Health 2023 shares outstanding were 0.492B, a 0.82% increase from 2022.
|
Elanco Animal Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 496 |
| 2024 | 497 |
| 2023 | 492 |
| 2022 | 488 |
| 2021 | 487 |
| 2020 | 441 |
| 2019 | 370 |
| 2018 | 314 |
| 2017 | 293 |
| 2016 | 293 |
| 2015 | |
|
Elanco Animal Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-03-31 | 506 |
| 2025-12-31 | 496 |
| 2025-09-30 | 497 |
| 2025-06-30 | 500 |
| 2025-03-31 | 499 |
| 2024-12-31 | 497 |
| 2024-09-30 | 498 |
| 2024-06-30 | 494 |
| 2024-03-31 | 496 |
| 2023-12-31 | 492 |
| 2023-09-30 | 493 |
| 2023-06-30 | 493 |
| 2023-03-31 | 493 |
| 2022-12-31 | 488 |
| 2022-09-30 | 488 |
| 2022-06-30 | 488 |
| 2022-03-31 | 492 |
| 2021-12-31 | 487 |
| 2021-09-30 | 487 |
| 2021-06-30 | 487 |
| 2021-03-31 | 487 |
| 2020-12-31 | 441 |
| 2020-09-30 | 462 |
| 2020-06-30 | 413 |
| 2020-03-31 | 404 |
| 2019-12-31 | 370 |
| 2019-09-30 | 373 |
| 2019-06-30 | 367 |
| 2019-03-31 | 366 |
| 2018-12-31 | 314 |
| 2018-09-30 | 301 |
| 2018-06-30 | 293 |
| 2018-03-31 | 293 |
| 2017-12-31 | |
| 2017-09-30 | 366 |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.500B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |